ILMN vs MDXG: fair value comparison
Illumina, Inc. and MiMedx Group, Inc. · Updated 2026-10-19
Both currently screen as overvalued on TickrTrends' Forward Fair Value model. Within Healthcare, ILMN currently sits closer to the top of our ranking by discount to fair value.
| ILMN | MDXG | |
|---|---|---|
| Verdict | Overvalued | Overvalued |
| Last price | $278.17 | $4.43 |
| 12-month range | $95.03–$293.69 | $3.08–$7.96 |
| Rank by discount to fair value | #92 of 108 Healthcare | #93 of 108 Healthcare |
| Quality grade | B | B |
| Leverage | Moderate | Low |
| Margin trend | Stable | Contracting |
| Revenue growth | Modest | Declining |
| RSI zone | Neutral | Neutral |
| 50/200-day trend | Uptrend | Downtrend |
| DCF cross-check | — | Overvalued |
| 52-week position | The top quarter | The lower-middle quarter |
Full single-stock breakdowns: ILMN fair value analysis · MDXG fair value analysis